| Dr Mukesh Maganbhai Patel, MD | |
|
1628 Oak Tree Rd, Edison, NJ 08820-2841 | |
| (732) 205-9070 | |
| (732) 205-9165 |
| Full Name | Dr Mukesh Maganbhai Patel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 1628 Oak Tree Rd, Edison, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598740292 | NPI | - | NPPES |
| 52306 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA05531500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Edison, NJ | Hospital |
| Entity Name | Newark Beth Israel Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033210323 PECOS PAC ID: 3173437464 Enrollment ID: O20031119000754 |
News Archive
Researchers found that more than 97 percent of the surgeries for appendicitis were laparoscopic, or minimally invasive, and most patients were discharged the same day or the next day. Only 3 percent of the procedures resulted in complications.
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mukesh Maganbhai Patel, MD 1628 Oak Tree Rd, Edison, NJ 08820-2841 Ph: (732) 205-9070 | Dr Mukesh Maganbhai Patel, MD 1628 Oak Tree Rd, Edison, NJ 08820-2841 Ph: (732) 205-9070 |
News Archive
Researchers found that more than 97 percent of the surgeries for appendicitis were laparoscopic, or minimally invasive, and most patients were discharged the same day or the next day. Only 3 percent of the procedures resulted in complications.
McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.
Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.
› Verified 7 days ago
Dr. Vasilios Velmahos, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 113 James St, Edison, NJ 08820 Phone: 732-906-1900 Fax: 732-906-6666 | |
Dr. Pankaj Gupta, MD, MBA Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 31 Southfield Rd, Edison, NJ 08820 Phone: 860-989-8829 | |
Dr. Howard S. Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98 James St, Suite 313, Edison, NJ 08820 Phone: 732-635-0916 Fax: 732-494-4907 | |
Dr. Malvin S Keller, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 May St, Suite F, Edison, NJ 08837 Phone: 732-738-8855 Fax: 732-738-4141 | |
Charumathi Rathnakumar, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 35 Progress St, Suite A-4, Edison, NJ 08820 Phone: 732-514-9624 Fax: 732-377-3767 | |
Anil Kumar Singh, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1740 Oak Tree Rd Ste B, Edison, NJ 08820 Phone: 732-494-5000 Fax: 732-494-6698 | |
Dr. Aron A Barsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Ethel Rd, Suite 405b, Edison, NJ 08817 Phone: 732-287-0255 Fax: 732-287-0355 |